HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

elsulfavirine

Also Known As:

Elpida; N-(4-((2-(4-bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorophenyl)acetyl)amino)-3-chlorophenyl)sulfonylpropanamide; R-1206; R1206

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Kalinin, Stanislav: 1 article (12/2021)
2.	Krasavin, Mikhail: 1 article (12/2021)
3.	Nocentini, Alessio: 1 article (12/2021)
4.	Savchuk, Nikolay: 1 article (12/2021)
5.	Supuran, Claudiu T: 1 article (12/2021)
6.	Yakubova, Elena: 1 article (12/2021)
7.	Al-Salama, Zaina T: 1 article (10/2017)

Related Diseases

1.	HIV Infections (HIV Infection) 10/01/2017 - "Elsulfavirine (Elpida®) is a new-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) being developed by Viriom for the treatment and prevention of human immunodeficiency virus (HIV) infections. "
2.	Neuralgia (Stump Neuralgia) 12/01/2021 - "Biochemical profiling against twelve human carbonic anhydrase (CA, EC 4.2.1.1) isoforms showed that while elsulfavirine was a weak inhibitor of all isoforms, VM1500A potently and selectively inhibited human (h) hCA VII isoform, a proven target for the therapy of neuropathic pain. "
3.	Infections 10/01/2017 - "In June 2017, elsulfavirine received its first global approval in Russia for the treatment of HIV-1 infections in combination with other antiretroviral medicines. "
4.	Acquired Immunodeficiency Syndrome (AIDS) 12/01/2021 - "The non-nucleoside reverse transcriptase inhibitor VM1500A is approved for the treatment of HIV/AIDS in its N-acyl sulphonamide prodrug form elsulfavirine (Elpida®). "

Related Drugs and Biologics

1.	Reverse Transcriptase Inhibitors
2.	Nucleosides
3.	Protein Isoforms (Isoforms)
4.	Prodrugs
5.	Carbonic Anhydrases (Carbonic Anhydrase)

Related Therapies and Procedures

1.	Therapeutics